Atlas Trials

Translating Neuroprediction Into Precision Medicine Via Brain Priming

Clinical trial NCT03370510 · TERMINATED

Trial details

NCT number
NCT03370510
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2018-12-07
Primary completion
2021-07-28
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.